Expediating Drug Development through Preclinical Oncology Studies

Our preclinical oncology support expedites the development of new cancer drugs by analyzing drug interactions, tumor growth effects, potential side effects, and identifying biomarkers for personalized therapies. Oour preclinical oncology CRO services inform optimal dosing and strategies for subsequent trials, improving the efficiency in delivering effective cancer treatments. 

Preclinical oncology studies utilize various methodologies, each serving a specific purpose, these methodologies aim to investigate the complexities of cancer biology, the discovery of potential therapies, and facilitate the development of effective treatments. 

Cell Culture and In Vitro Assays 

Genomic Analysis 

Drug Screening 

Imaging Techniques 

Xenograft and Orthotopic Models 

In Vivo Imaging 

Immunotherapy Studies 

Molecular Profiling 

Pharmacokinetic and Pharmacodynamic studies 

Toxicity and Safety studies 

Applications of Oncology Models in Cancer Research

As a preclinical oncology CRO we offer numerous advantages that make us an ideal partner for your research endeavors, here are some key reasons why you should choose to collaborate with us to advance your studies. 

Specialized Expertise

With a focus on preclinical oncology studies, our team of experienced researchers and scientists enables us to deliver precise and impactful results.

Resource Optimization

Achieving successful preclinical oncology research relies on having efficient resource utilization; we recognize this significance and employ strategic allocation and planning in our approach. 

Tailored Solutions

We acknowledge that all research objectives are unique, ensuring that our solutions are tailored to meet your specific needs, this alignment allows every aspect of your preclinical oncology study to be focused on your goals. 

Rapid Turnaround

We understand the time-sensitive nature of research, particularly when it comes to your preclinical oncology projects. That’s why we are committed to efficiency and a streamlined approach, our rapid turnaround ensure that you will receive timely results, without compromising the quality of your data or its accuracy. Our processes keep your research on track, when you choose us as your preclinical oncology CRO, you can rely on us to deliver swift and reliable outcomes. 

Key Functions of Preclinical Oncology Research

Additional Preclinical Oncology Research Services

Explore our range of supplementary services that can be tailored to elevate your preclinical oncology studies: 

Pharmacology Services 

Forming the foundation of our preclinical oncology studies, we offer a range of techniques and assays that explore the complex interactions between compounds and biological systems, our solutions are customized to meet your research requirements as a trusted preclinical oncology CRO. 

Histology

Explore tissue samples at a microscopic level and benefit from cellular visualization with our Histology services, providing information on cellular architecture and changes in diseased states. 

In Vivo Disease Models

We specialize in novel model development and characterization, with our oncology, NASH, geriatric, and ophthalmology models you will be able to explore therapeutic areas. 

Cell-Based Assays

With our Cell-Based Assays investigate the behavior of cells in response to a variety of stimuli. Discover insights into the efficacy of your target drug its toxicity, and cellular signaling pathways. 

Toxicology Studies

Essential in preclinical oncology studies, toxicology analysis will help researchers develop and test targeted therapies, immunotherapies, and therapeutic interventions of new treatments. 

PK/PD Services

Pharmacokinetic and Pharmacodynamic studies aid in navigating the complex dynamics of ADME, developing your understanding of how compounds interact within the body. 

Are you ready to revolutionize your preclinical oncology studies?

Choose us as your Preclinical Oncology CRO and propel your research forward